Drug firm Cipla Thursday said it has signed an agreement to acquire 26 per cent stake on a fully diluted basis in AMPSolar Power Systems Pvt Ltd for a cash consideration of up to Rs 12.90 crore.
AMPSolar Power Systems Pvt Ltd is a wholly owned subsidiary of AMPSolar Technology Pvt Ltd and is a special purpose vehicle formed for the purpose of setting up a captive solar power project in Maharashtra, Cipla said in a filing to the BSE.
Cipla will acquire and maintain 26 per cent stake on a fully diluted basis in AMPSolar throughout the term of the power purchase agreement, share purchase, subscription and share holders agreement and other transaction documents, it added.
The indicative time-period for share purchase is June 12, 2019, it added.
Shares of Cipla Ltd closed at Rs 563.45 per scrip on the BSE, up 1.70 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
